Finehart Tablet is a combination medication containing Atorvastatin 10mg and Fenofibrate 200mg, designed to manage abnormal lipid levels in patients at risk of cardiovascular diseases. Atorvastatin, a statin, works by inhibiting HMG-CoA reductase, an enzyme involved in cholesterol synthesis, thereby effectively lowering low-density lipoprotein (LDL) cholesterol and total cholesterol levels. Fenofibrate, a fibric acid derivative, primarily reduces triglycerides and can modestly increase high-density lipoprotein (HDL) cholesterol. Together, these agents provide a comprehensive approach to dyslipidemia by targeting multiple lipid fractions, making Finehart Tablet suitable for patients with mixed hyperlipidemia or those who do not achieve adequate lipid control with monotherapy. The combined action helps reduce the risk of atherosclerosis, heart attacks, and strokes. Finehart Tablet should be taken as prescribed by a healthcare professional, typically once daily with food to enhance absorption and minimize gastrointestinal discomfort. Patients should undergo regular lipid profile monitoring and liver function tests during therapy. Caution is advised in patients with liver or kidney impairment, and it is contraindicated in pregnancy and lactation. Lifestyle modifications including diet, exercise, and smoking cessation are recommended alongside medication for optimal results.